[HTML][HTML] Recent advances from basic and clinical studies of esophageal squamous cell carcinoma

S Ohashi, S Miyamoto, O Kikuchi, T Goto, Y Amanuma… - Gastroenterology, 2015 - Elsevier
Esophageal squamous cell carcinoma (ESCC) is one of the most aggressive squamous cell
carcinomas and is highly prevalent in Asia. Alcohol and its metabolite, acetaldehyde, are …

Update on primary head and neck mucosal melanoma

F López, JP Rodrigo, A Cardesa, A Triantafyllou… - Head & …, 2016 - Wiley Online Library
Primary mucosal melanomas (PMMs) of the head and neck are uncommon malignancies
that arise mainly in the nasal cavity and paranasal sinuses, followed by the oral cavity. The …

[HTML][HTML] Sunitinib alone or after nephrectomy in metastatic renal-cell carcinoma

A Méjean, A Ravaud, S Thezenas… - … England Journal of …, 2018 - Mass Medical Soc
Background Cytoreductive nephrectomy has been the standard of care in metastatic renal-
cell carcinoma for 20 years, supported by randomized trials and large, retrospective studies …

[HTML][HTML] ARTSCAN III: a randomized phase III study comparing chemoradiotherapy with cisplatin versus cetuximab in patients with locoregionally advanced head and …

M Gebre-Medhin, E Brun, P Engström… - Journal of Clinical …, 2021 - ncbi.nlm.nih.gov
PURPOSE We performed an open-label randomized controlled phase III study comparing
treatment outcome and toxicity between radiotherapy (RT) with concomitant cisplatin versus …

Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial

E Paci, D Puliti, AL Pegna, L Carrozzi, G Picozzi… - Thorax, 2017 - thorax.bmj.com
Background ITALUNG is contributing to the European evaluation of low-dose CT (LDCT)
screening for lung cancer (LC). Methods Eligible subjects aged 55–69 years, smokers or ex …

[HTML][HTML] ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant …

J Hoeppner, F Lordick, T Brunner, T Glatz, P Bronsert… - BMC cancer, 2016 - Springer
Background Recent randomized controlled trials comparing neoadjuvant chemoradiation
plus surgery or perioperative chemotherapy plus surgery with surgery alone showed …

[HTML][HTML] A miRNA-based diagnostic model predicts resectable lung cancer in humans with high accuracy

K Asakura, T Kadota, J Matsuzaki, Y Yoshida… - Communications …, 2020 - nature.com
Lung cancer, the leading cause of cancer death worldwide, is most frequently detected
through imaging tests. In this study, we investigated serum microRNAs (miRNAs) as a …

[图书][B] Cancer on trial: oncology as a new style of practice

P Keating, A Cambrosio - 2019 - degruyter.com
Until the early 1960s, cancer treatment consisted primarily of surgery and radiation therapy.
Most practitioners then viewed the treatment of terminally ill cancer patients with heroic …

Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial

E Quoix, R Ramlau, V Westeel, Z Papai… - The lancet …, 2011 - thelancet.com
Background Chemotherapy is the standard of care for advanced stages of non-small-cell
lung cancer (NSCLC). TG4010 is a targeted immunotherapy based on a poxvirus (modified …

Treatment and survival of resected and unresected distal cholangiocarcinoma: a nationwide study

M Strijker, A Belkouz, LG van der Geest… - Acta …, 2019 - Taylor & Francis
Background: Population-based data on distal cholangiocarcinoma (DCC) from the Western
world are not available, albeit essential to identify areas for improvement. This study …